Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient s bloodstream to maintain it within a therapeutic window.
/PRNewswire/ ProciseDx Inc. announces that it is being acquired by Biosynex S.A., a French diagnostics company that specializes in point of care testing..
Visiongain has published a new report entitled Biosimilars and Follow-on Biologics 2023-2033. It includes profiles of Biosimilars and Follow-on Biologics.